|WHEN||November 08, 2008 @ 8:00am - 5:00pm|
Mark your calendar and come join us for the highly anticipated 4th annual SABPA Pacific Forum and network with the Whos Who of life science across the Pacific Rim!
The 4th Annual SABPA Pacific Forum on Life Science Alliances
Venue: Copley Intl Conference Center, The Institute of Americas, UCSD, San Diego
Topics: Cross-Pacific Trends in Investment/Financing, Licensing/Partnering/M&A, and Outsourcing
The Annual Pacific Forum organized by Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) has provided the community an essential platform for entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology and life science alliances across the Pacific Rim.
The Pacific Forum is one of the SABPAs flagship annual conferences and broke many records last year: attracting over 300 attendees, five media outlets, and supported by 22 corporate sponsors and eleven event partners including BIOCOM and CONNECT.
This year the forum has invited prominent industry leaders from various sectors of the life science industries in the US and China/India to explore the topics of cross-Pacific partnerships, innovation, and future outlook for the global R&D and commercialization efforts. Many new companies and speakers will be featured.
Click here for the article published in PharmExecutive.
Click here for the Press release.
$30/person, $15/post-doc for online registration until Nov 6. $40/person onsite.
Online registration is closed now. See you this coming Saturday!
Click here if you need to change your registraion.
Click here for Program Agenda
Zhu Shen Ph.D., MBA, CEO, BioForesight
SABPA Board Member & Vice Chairman, Forum Chair
“Unleash the Dragon- Overview of Emerging China Life Science Industry”
Hui Li, Ph.D., Senior Principle Scientist, Pfizer Global
La Jolla, SABPA President, Vice Chairman & Board Member
Joshua Berlin, Executive Editor & Senior Publications Manager, PhamAsia News/F-D-C Reports, Inc./Elsevier
“Trans-Pacific Partnering & Licensing Opportunities & Trends”
Richard Gallagher, Ph.D. Editor and Publisher,
John Sterling, Editor-in-Chief, Genetic Engineering & Biotechnology News
Rob Waters, Health & Science Writer, Bloomberg News
Xu Bai, Ph.D., Professor, College of Chemistry and the School of Pharmaceutical Sciences, Director,
Center for Combinatorial Chemistry and Drug Discovery, Jilin University
Peng Chen, Ph.D., J.D., Partner, Morrison & Foerster
“The Continued Weakening of Patent Rights”
Paul DeRidder, M.D., Ph.D., Venture Partner, Crystal Cove Capital LLC
“Global Trends in Venture Capital 2007 Survey”
Ding Ding, Ph.D., Senior Equity Analyst, China Healthcare
Susquehanna Financial Group, LLP
Cliff C. Guan, Senior Manager, International Tax Services – China Practice Leader, Deloitte LLP
Yun He, Ph.D., Vice President, Research, BioDuro
Harry Hui-yin Li, Ph.D., CEO, Wilmington Pharmatech
Henry Nordhoff, Chairman & CEO, Gen-probe
James Schaeffer, Ph.D., Executive Director, Merck & Company
“Embracing Partnerships, Merck Partnering Brief Overview”
Greg Scott, President & CEO, ChinaBio Accelerator
“The State of China Biotech”
Tim Scott, President, Pharmatek
Shawn Shi, Ph.D., Executive Vice President, Sundia Meditech
CJ Wang, Ph.D., Vice President, Business Development,
Jintao Zhang, Ph.D., CEO, Shanghai Medicilon
Wei Zhou, Ph.D., J.D., Partner, Wilson Sonsini Goodrich & Rosati